ART-I02

N/A

Report date: 2024/11/07 20:00:06

Base Information

Drug NameART-I02
Drug Alias NameRecombinant AAV type2/5 containing a hIFN-b geneAAV5.NF-kB.IFN-βART-I02
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceInterferon beta stimulants
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaNetherlands
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArthrogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArthrogen
Active IndicationsN/A
Inactive IndicationsOsteoarthritisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A